[HTML][HTML] TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case–Control Study
F Šušak, N Vrsaljko, A Vince, N Papić - Microorganisms, 2023 - repozitorij.mef.unizg.hr
Abstract (english) Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic
liver disease in Western countries, has been identified as a possible risk factor for COVID-19 …
liver disease in Western countries, has been identified as a possible risk factor for COVID-19 …
TGF beta as a prognostic biomarker of COVID-19 severity in patients with NAFLD-a prospective case-control study.
F Susak, N Vrsaljko, A Vince, N Papic - 2023 - cabidigitallibrary.org
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - search.proquest.com
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case–Control Study
F Šušak, N Vrsaljko, A Vince, N Papić - Microorganisms, 2023 - repozitorij.unizg.hr
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD-A Prospective Case-Control Study.
F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study.
F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - search.ebscohost.com
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD-A Prospective Case-Control Study
F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
[HTML][HTML] TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …
[PDF][PDF] TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study. Microorganisms 2023, 11, 1571
F Susak, N Vrsaljko, A Vince, N Papic - 2023 - repozitorij.mef.unizg.hr
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …
Western countries, has been identified as a possible risk factor for COVID-19 severity …